AREV Life Sciences Global Corp.
AREVF
$0.01
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.30K | 5.60K | 29.00K | 100.00 | 11.10K |
| Total Receivables | 41.20K | 40.90K | 37.50K | 36.00K | 36.90K |
| Inventory | -- | -- | -- | -- | 14.50K |
| Prepaid Expenses | 8.30K | 9.10K | 9.50K | 13.10K | 34.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 50.90K | 55.60K | 76.00K | 49.20K | 97.40K |
|
|
|||||
| Total Current Assets | 50.90K | 55.60K | 76.00K | 49.20K | 97.40K |
| Net Property, Plant & Equipment | 106.80K | 119.60K | 127.30K | 137.40K | 165.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 157.70K | 175.20K | 203.30K | 186.70K | 262.80K |
|
|
|||||
| Total Accounts Payable | 585.50K | 583.40K | 611.70K | 595.10K | 772.50K |
| Total Accrued Expenses | 324.40K | 338.40K | 295.00K | -- | 68.20K |
| Short-term Debt | 90.20K | 92.20K | 28.20K | 4.00K | 10.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.30K | 17.70K | 17.30K | 17.30K | 26.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 274.10K | -- |
| Total Other Current Liabilities | -- | -- | -- | 274.10K | -- |
| Total Current Liabilities | 1.02M | 1.03M | 952.30K | 890.50K | 877.70K |
|
|
|||||
| Total Current Liabilities | 1.02M | 1.03M | 952.30K | 890.50K | 877.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 90.20K | 92.20K | 28.20K | 4.00K | 10.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.02M | 1.03M | 952.30K | 890.50K | 877.70K |
|
|
|||||
| Common Stock & APIC | 10.14M | 10.35M | 10.13M | 10.10M | 9.91M |
| Retained Earnings | -13.21M | -13.47M | -13.09M | -12.97M | -12.84M |
| Treasury Stock & Other | 2.21M | 2.26M | 2.21M | 2.16M | 2.31M |
| Total Common Equity | -859.80K | -856.50K | -749.00K | -703.90K | -614.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -859.80K | -856.50K | -749.00K | -703.90K | -614.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -859.80K | -856.50K | -749.00K | -703.90K | -614.90K |
|
|
|||||